Literature DB >> 30831052

Use of propensity score and disease risk score for multiple treatments with time-to-event outcome: a simulation study.

Di Zhang1, Jessica Kim2.   

Abstract

Propensity score (PS) and disease risk score (DRS) are often used in pharmacoepidemiologic safety studies. Methods of applying these two balancing scores are extensively studied in binary treatment settings. However, the use of PS and DRS is not well understood in the case of non-ordinal multiple treatments. Some PS methods of multiple treatments have been implemented since the theoretical establishment. Nevertheless, most of the work applies to continuous or binary outcomes. Little work has been done for time-to-event outcomes. In this study, we extend the application of the PS and DRS methods to time-to-event outcomes in multiple treatment settings. The analytical approaches include weighing, matching, stratification, and regression. Simulation studies with rare event rates are conducted to evaluate the performances of different methods. Different treatment-covariates and outcome-covariates strength of associations are considered. Additionally, the impacts of imbalanced designs and large or limited PS overlaps are investigated on various analytical approaches. We found that the inverse probability treatment weighting with bootstrap variance estimator, the generalized PS matching, and the Cox regression estimated DRS in full cohort generally performed well in multiple treatment settings. This study aims to provide additional guidance for researchers on PS and DRS analyses in pharmacoepidemiologic observational studies.

Entities:  

Keywords:  Multinomial logit model; bootstrap; inverse probability treatment weight; matching; observational study

Year:  2019        PMID: 30831052     DOI: 10.1080/10543406.2019.1584205

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  1 in total

1.  Role of Removed Lymph Nodes on the Prognosis of M0 Small-Bowel Neuroendocrine Tumors: a Propensity Score Matching Analysis from SEER Database.

Authors:  Jie-Bin Xie; Yue-Shan Pang; Xun Li; Xiao-Ting Wu
Journal:  J Gastrointest Surg       Date:  2021-06-09       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.